This paper reviews the design and application of mammalian synthetic gene circuits for biopharmaceutical manufacturing.
First-pass extracted concept
mammalian synthetic gene circuits
Candidate: concept label1 source documents4 linked claims
Live refresh every 5sNext refresh in 5s
Evidence Snippets
Supporting Sources
Linked Claims
The review highlights potential applications of mammalian synthetic gene circuits to monoclonal antibody glycosylation control, CAR-T cell therapy safety, and gene therapy viral vector yields.
Transcription factors, DNA-binding proteins, and RNA are described as input and regulatory modules in mammalian synthetic gene circuits.
Computational modelling is presented as a driver for circuit optimisation.
The paper reviews the design and application of mammalian synthetic gene circuits for biopharmaceutical manufacturing.